Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

STROSTRO
3 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in SUTRO BIOPHARMA INC

CITADEL ADVISORS LLC holds 101,965 shares of STRO (SUTRO BIOPHARMA INC), worth $3.4M as of 2026-Q2. The position was decreased (-13.3% shares). STRO represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$3.4M

Current Shares

101,965

Total Value Change

+$3M

Total Shares Change

+69,880

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
101,965
-13.3%
$3.4M0.0%$33.20
0
2026-Q1
Increased
117,537
+266.3%
$2.9M0.0%$19.70
42
2025-Q4
New
32,085
-
$371,2230.0%$11.67
33

Other major holders of STRO: BlackRock, Inc., BALYASNY ASSET MANAGEMENT L.P., VANGUARD CAPITAL MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used